Search

Search bills, members, committees and pages...

Sign In

NICOLAS MAGALLANES

PreviousNext

42 federal lobbying filings, 2023 to 2026.

NICOLAS MAGALLANES is a registered lobbyist named on 42 federal lobbying filings, 2023 to 2026, reporting $1.6M across them.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.

Firms

3 they have filed under, by filings.

RegistrantFilingsReported
TODD STRATEGY GROUP28$1.6M
ILLUMINA, INC.13—
IOVANCE BIOTHERAPEUTICS, INC.1—

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
202625$1.4M—
20257$170K$2M
20245—$1.6M
20235—$3.8M

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues26
MMMMedicare/Medicaid20
TRDTrade (domestic/foreign)13
DEFDefense8
BUDBudget/Appropriations6
PHAPharmacy6
GOVGovernment Issues4
TARTariff (miscellaneous tariff bills)3
TAXTaxation/Internal Revenue Code3
HOMHomeland Security2
COMCommunications/Broadcasting/Radio/TV1

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 1672Maintaining Investments in New Innovation Act4
H.R. 2214DRUG Act3
H.R. 946ORPHAN Cures Act3
S. 1040Drug Competition Enhancement Act3
S. 1041Affordable Prescriptions for Patients Act3
S. 864HELP Copays Act3
H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.2
H.R. 1968Full-Year Continuing Appropriations and Extensions Act, 20252
H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…1
H.R. 4299Protecting Patient Access to Cancer and Complex Therapies Act1
H.R. 4312SCORE Act1
H.R. 5376Impacts and Outcomes for Health Career Training Act1
H.R. 5539POW Priority Care Act of 20251
S. 3131USS Frank E. Evans Act1
S. 832EPIC Act of 20251

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
MENARINI GROUPTODD STRATEGY GROUP2026 second_quarter$30KAug 3, 2026
TAKEDA PHARMACEUTICALS AMERICA, INC.TODD STRATEGY GROUP2026 second_quarter$50KJul 21, 2026
SUNBOUND HOMESTODD STRATEGY GROUP2026 second_quarter$50KJul 21, 2026
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICATODD STRATEGY GROUP2026 second_quarter$80KJul 21, 2026
PFIZER INC.TODD STRATEGY GROUP2026 second_quarter$60KJul 21, 2026
NOVO NORDISK INC.TODD STRATEGY GROUP2026 second_quarter$60KJul 21, 2026
MCKESSON CORPORATIONTODD STRATEGY GROUP2026 second_quarter$50KJul 21, 2026
JOHNSON & JOHNSON SERVICES, INC.TODD STRATEGY GROUP2026 second_quarter$100KJul 21, 2026
GENENTECH, INC.TODD STRATEGY GROUP2026 second_quarter$60KJul 21, 2026
FOX CORPORATIONTODD STRATEGY GROUP2026 second_quarter$50KJul 21, 2026
COMPASS PATHWAYS INC.TODD STRATEGY GROUP2026 second_quarter$80KJul 21, 2026
THE COALITION FOR 21ST CENTURY MEDICINETODD STRATEGY GROUP2026 second_quarter$90KJul 21, 2026
BIOGEN, INC.TODD STRATEGY GROUP2026 second_quarter$50KJul 20, 2026
ASTRAZENECA PHARMACEUTICALS LPTODD STRATEGY GROUP2026 second_quarter$80KJul 20, 2026
ASTELLAS PHARMA US, INC.TODD STRATEGY GROUP2026 second_quarter$50KJul 20, 2026
AMGEN INC.TODD STRATEGY GROUP2026 second_quarter$80KJul 20, 2026
AMERICAN SOCIETY OF NEPHROLOGYTODD STRATEGY GROUP2026 second_quarter$40KJul 20, 2026
ALNYLAM PHARMACEUTICALS, INC.TODD STRATEGY GROUP2026 second_quarter$60KJul 20, 2026
NOVARTIS, INC.TODD STRATEGY GROUP2026 second_quarter$60KJul 17, 2026
MENARINI GROUPTODD STRATEGY GROUP2026 second_quarter—Jul 13, 2026
SUNBOUND HOMESTODD STRATEGY GROUP2026 first_quarter—Jul 13, 2026
ELI LILLY AND COMPANYTODD STRATEGY GROUP2026 second_quarter$80KJul 13, 2026
PFIZER INC.TODD STRATEGY GROUP2026 first_quarter$60KApr 20, 2026
BIOGEN, INC.TODD STRATEGY GROUP2026 first_quarter$50KApr 20, 2026
ALNYLAM PHARMACEUTICALS, INC.TODD STRATEGY GROUP2026 first_quarter$60KApr 20, 2026